nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR7—sympathetic nervous system—adrenal gland cancer	0.0337	0.173	CbGeAlD
Cabergoline—HTR7—vein—adrenal gland cancer	0.0315	0.162	CbGeAlD
Cabergoline—HTR2A—sympathetic nervous system—adrenal gland cancer	0.021	0.108	CbGeAlD
Cabergoline—HTR2A—vein—adrenal gland cancer	0.0197	0.101	CbGeAlD
Cabergoline—HTR2A—urine—adrenal gland cancer	0.0115	0.0591	CbGeAlD
Cabergoline—CYP3A4—urine—adrenal gland cancer	0.0107	0.0547	CbGeAlD
Cabergoline—HTR2B—adrenal cortex—adrenal gland cancer	0.00571	0.0293	CbGeAlD
Cabergoline—ADRB1—cardiac atrium—adrenal gland cancer	0.00494	0.0253	CbGeAlD
Cabergoline—ADRA2C—adrenal cortex—adrenal gland cancer	0.0045	0.0231	CbGeAlD
Cabergoline—HTR2B—adrenal gland—adrenal gland cancer	0.00412	0.0211	CbGeAlD
Cabergoline—HTR7—gonad—adrenal gland cancer	0.00405	0.0208	CbGeAlD
Cabergoline—DRD2—pituitary gland—adrenal gland cancer	0.00374	0.0192	CbGeAlD
Cabergoline—ADRA2C—cardiac atrium—adrenal gland cancer	0.00372	0.0191	CbGeAlD
Cabergoline—HTR1A—adrenal gland—adrenal gland cancer	0.0037	0.0189	CbGeAlD
Cabergoline—ADRA2C—pituitary gland—adrenal gland cancer	0.00363	0.0186	CbGeAlD
Cabergoline—HTR7—adrenal gland—adrenal gland cancer	0.00353	0.0181	CbGeAlD
Cabergoline—ADRA1A—adrenal gland—adrenal gland cancer	0.00341	0.0175	CbGeAlD
Cabergoline—ADRA2C—adrenal gland—adrenal gland cancer	0.00325	0.0166	CbGeAlD
Cabergoline—ADRA2A—gonad—adrenal gland cancer	0.00297	0.0152	CbGeAlD
Cabergoline—ADRA2A—cardiac atrium—adrenal gland cancer	0.00297	0.0152	CbGeAlD
Cabergoline—ADRA2A—pituitary gland—adrenal gland cancer	0.0029	0.0149	CbGeAlD
Cabergoline—ADRA2A—adrenal gland—adrenal gland cancer	0.00259	0.0133	CbGeAlD
Cabergoline—HTR2A—gonad—adrenal gland cancer	0.00253	0.013	CbGeAlD
Cabergoline—HTR2A—pituitary gland—adrenal gland cancer	0.00247	0.0126	CbGeAlD
Cabergoline—HTR2A—adrenal gland—adrenal gland cancer	0.0022	0.0113	CbGeAlD
Cabergoline—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000186	0.000231	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—POMC—adrenal gland cancer	0.000186	0.000231	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000185	0.00023	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000185	0.00023	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	0.000184	0.000229	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—BRAF—adrenal gland cancer	0.000184	0.000228	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000184	0.000228	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000183	0.000227	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.000183	0.000227	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000183	0.000227	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000183	0.000227	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000181	0.000225	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000181	0.000225	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.00018	0.000223	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.000179	0.000223	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000179	0.000222	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000179	0.000222	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TERT—adrenal gland cancer	0.000179	0.000222	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000178	0.000221	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.000178	0.000221	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000177	0.000219	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000177	0.000219	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000174	0.000216	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000174	0.000216	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000174	0.000216	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	0.000173	0.000215	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000171	0.000213	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TERT—adrenal gland cancer	0.000171	0.000213	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000171	0.000213	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000171	0.000213	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000171	0.000212	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	0.000169	0.00021	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000168	0.000209	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000168	0.000208	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	0.000166	0.000207	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000165	0.000205	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	0.000165	0.000205	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000165	0.000205	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000165	0.000205	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000164	0.000204	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000163	0.000203	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.000163	0.000203	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	0.000163	0.000202	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	0.000161	0.000201	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000161	0.0002	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.00016	0.000199	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000159	0.000198	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000159	0.000198	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000158	0.000197	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000158	0.000196	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000158	0.000196	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000157	0.000196	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000157	0.000195	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000157	0.000195	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000156	0.000193	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—BAD—adrenal gland cancer	0.000156	0.000193	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000155	0.000193	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000155	0.000192	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000154	0.000191	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000154	0.000191	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000154	0.000191	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000154	0.000191	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000153	0.00019	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000153	0.00019	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000153	0.00019	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000152	0.000189	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000152	0.000189	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.000152	0.000189	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000152	0.000188	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000151	0.000188	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.00015	0.000187	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000149	0.000185	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—BAD—adrenal gland cancer	0.000149	0.000185	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000148	0.000184	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000147	0.000182	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000146	0.000181	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000145	0.00018	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000144	0.000179	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—POMC—adrenal gland cancer	0.000143	0.000178	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000143	0.000178	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000143	0.000178	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000143	0.000177	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.000142	0.000177	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000142	0.000177	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	0.000142	0.000176	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000141	0.000176	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000141	0.000175	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.00014	0.000174	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.00014	0.000174	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000139	0.000173	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000139	0.000172	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	0.000139	0.000172	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000138	0.000171	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000138	0.000171	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—POMC—adrenal gland cancer	0.000137	0.000171	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000137	0.000171	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	0.000137	0.000171	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000136	0.000169	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000136	0.000169	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	0.000136	0.000168	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	0.000136	0.000168	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000135	0.000168	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000135	0.000167	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000134	0.000167	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000134	0.000166	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000134	0.000166	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000133	0.000165	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000133	0.000165	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000133	0.000165	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.000132	0.000164	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.000132	0.000164	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000132	0.000164	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000131	0.000163	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.000131	0.000163	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00013	0.000162	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.00013	0.000161	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000129	0.000161	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000128	0.000159	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000126	0.000157	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000125	0.000156	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000125	0.000155	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000124	0.000154	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000124	0.000154	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000123	0.000153	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000122	0.000152	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000122	0.000151	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000122	0.000151	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000121	0.00015	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	0.000121	0.00015	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.00012	0.00015	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.00012	0.00015	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000119	0.000148	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000118	0.000147	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	0.000118	0.000146	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000117	0.000145	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000117	0.000145	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000117	0.000145	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000116	0.000145	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000115	0.000143	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000115	0.000142	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000114	0.000142	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000112	0.000139	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000112	0.000139	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	0.000111	0.000138	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.00011	0.000137	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.00011	0.000136	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	0.00011	0.000136	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000109	0.000135	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	0.000109	0.000135	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	0.000107	0.000133	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000107	0.000133	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000106	0.000132	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000106	0.000132	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000106	0.000131	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000105	0.000131	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	0.000105	0.000131	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000105	0.00013	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000104	0.00013	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000104	0.000129	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000104	0.000129	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000103	0.000128	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000102	0.000127	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000102	0.000126	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000102	0.000126	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000102	0.000126	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000101	0.000126	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000101	0.000126	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000101	0.000126	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	9.99e-05	0.000124	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—POMC—adrenal gland cancer	9.99e-05	0.000124	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	9.96e-05	0.000124	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	9.96e-05	0.000124	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	9.84e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	9.81e-05	0.000122	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	9.8e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	9.75e-05	0.000121	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	9.69e-05	0.00012	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	9.35e-05	0.000116	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—POMC—adrenal gland cancer	9.33e-05	0.000116	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	9.21e-05	0.000114	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	9.18e-05	0.000114	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	9.07e-05	0.000113	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	9.06e-05	0.000113	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	8.99e-05	0.000112	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	8.93e-05	0.000111	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	8.88e-05	0.00011	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TP53—adrenal gland cancer	8.83e-05	0.00011	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	8.82e-05	0.00011	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	8.79e-05	0.000109	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	8.7e-05	0.000108	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	8.7e-05	0.000108	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	8.6e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	8.35e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	8.25e-05	0.000102	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	8.11e-05	0.000101	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	8.06e-05	0.0001	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	7.99e-05	9.93e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	7.97e-05	9.9e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	7.93e-05	9.85e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	7.89e-05	9.8e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	7.86e-05	9.76e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	7.8e-05	9.69e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	7.76e-05	9.64e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	7.76e-05	9.63e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.58e-05	9.42e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	7.54e-05	9.37e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	7.41e-05	9.2e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	7.34e-05	9.12e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	7.22e-05	8.97e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	6.99e-05	8.68e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	6.89e-05	8.56e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	6.89e-05	8.56e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TP53—adrenal gland cancer	6.81e-05	8.46e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	6.76e-05	8.4e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	6.66e-05	8.27e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	6.62e-05	8.23e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.55e-05	8.14e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TP53—adrenal gland cancer	6.52e-05	8.1e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.42e-05	7.97e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GNAS—adrenal gland cancer	6.32e-05	7.85e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	6.28e-05	7.8e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	6.22e-05	7.73e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	6.22e-05	7.73e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	6.2e-05	7.7e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	6.14e-05	7.63e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	6.01e-05	7.46e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	5.98e-05	7.43e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	5.96e-05	7.4e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TP53—adrenal gland cancer	5.87e-05	7.29e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	5.81e-05	7.22e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TP53—adrenal gland cancer	5.79e-05	7.19e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	5.79e-05	7.19e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	5.72e-05	7.11e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	5.28e-05	6.55e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	5.27e-05	6.55e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	5.23e-05	6.49e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	5.19e-05	6.45e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	5.16e-05	6.41e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	5.08e-05	6.31e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	5.04e-05	6.27e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	5.02e-05	6.23e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	4.88e-05	6.06e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	4.8e-05	5.97e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	4.72e-05	5.87e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TP53—adrenal gland cancer	4.43e-05	5.5e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	4.36e-05	5.41e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	4.27e-05	5.3e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.26e-05	5.29e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	3.96e-05	4.93e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.39e-05	4.22e-05	CbGpPWpGaD
